Giorgio Zoli
About
In The Last Decade
Giorgio Zoli
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Epidemiology 521
- Surgery 358
- Genetics 308
- Gastroenterology 259
- Pathology and Forensic Medicine 137
Countries citing papers authored by Giorgio Zoli
This map shows the geographic impact of Giorgio Zoli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giorgio Zoli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giorgio Zoli more than expected).
Fields of papers citing papers by Giorgio Zoli
This network shows the impact of papers produced by Giorgio Zoli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giorgio Zoli. The network helps show where Giorgio Zoli may publish in the future.
Co-authorship network of co-authors of Giorgio Zoli
This figure shows the co-authorship network connecting the top 25 collaborators of Giorgio Zoli. A scholar is included among the top collaborators of Giorgio Zoli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giorgio Zoli. Giorgio Zoli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 7 | |
| 4 | 23 | |
| 5 | 39 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 28 | |
| 9 | 107 | |
| 10 | 27 | |
| 11 | 66 | |
| 12 | 13 | |
| 13 | 14 | |
| 14 | 51 | |
| 15 | 19 | |
| 16 | 40 | |
| 17 | 23 | |
| 18 | 29 | |
| 19 | Cytophilic antibodies cause leucocyte migration inhibition in coeliac disease. | 4 |
| 20 | Use of pyridoxine-alpha-ketoglutarate (PAK) in hepatic encephalopathy | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.